Abstract
The persistence of symptoms after recovery from Coronavirus 2019 (COVID-19) is defined as long COVID, an entity that had occurred among adults but which is not yet well characterized in pediatric ages. The purpose of this work was to present some of the data from a survey addressed to Italian pediatricians concerning the impact of long-COVID among children who recovered from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. The questionnaire was designed and pre-tested in February 2021 by a working group of experts from the Italian Pediatric Society for Allergy and Immunology (SIAIP). The survey was emailed once in March 2021 to a sample of Italian pediatricians. A total 267 Italian pediatricians participated in our survey. According to most pediatricians (97.3%), the persistence of symptoms is found in less than 20% of children. Specifically, with regard to the symptoms that persist even after swab negativization, fatigue was the most mentioned one (75.6%). Long-COVID would seem to be a phenomenon of limited occurrence in pediatric ages, affecting less than 20% of children. Among all of the symptoms, the one that was most prevalent was fatigue, a pathological entity that is associated with many viral diseases.
Highlights
To better define the discussion in this study, we referred to the guidelines produced by the National Institute for Health and Care Excellence (NICE), published on 18 December
The questions in the questionnaire focused on the clinical and management aspects related to the COVID-19 pandemic in pediatric age with its relative impact among
A total of267 Italian pediatricians participated in our survey and provided responses to our electronic questionnaire by 31 March 2021
Summary
It is known that many patients who recover from the acute phase of the Coronavirus disease 2019 (COVID-19) continue to have clinical manifestations or develop new ones. This finding has alerted the scientific community, and researchers immediately began investigating these alterations and the possible correlation with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The term “long-COVID” was coined to indicate these manifestations [1]. To better define the discussion in this study, we referred to the guidelines produced by the National Institute for Health and Care Excellence (NICE), published on 18 December
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
